TY - JOUR
T1 - Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort
AU - Tartaglione, Immacolata
AU - Strunk, Crawford
AU - Antwi-Boasiako, Charles
AU - Andemariam, Biree
AU - Colombatti, Raffaella
AU - Asare, Eugenia Vicky
AU - Piccone, Connie M.
AU - Manwani, Deepa
AU - Boruchov, Donna
AU - Tavernier, Fitz
AU - Farooq, Fatimah
AU - Akatue, Sophia
AU - Oteng, Bianca
AU - Urbonya, Rebekah
AU - Wilson, Samuel
AU - Owda, Ahmed
AU - Bamfo, Rose
AU - Boatemaa, Gifty Dankwah
AU - Rao, Sudha
AU - Zempsky, William
AU - Sey, Fredericka
AU - Inusa, Baba PD
AU - Perrotta, Silverio
AU - Segbefia, Catherine
AU - Campbell, Andrew D.
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/5
Y1 - 2021/5
N2 - Pain is a hallmark of Sickle Cell Disease (SCD) affecting patients throughout their life; the first pain crisis may occur at any age and is often the first presentation of the disease. Universal newborn screening identifies children with SCD at birth, significantly improving morbidity and mortality. Without early screening, diagnosis is generally made after disease manifestations appear. The Consortium for the Advancement of Sickle Cell Research (CASiRe) is an international collaborative group evaluating the clinical severity of subjects with SCD using a validated questionnaire and medical chart review, standardized across 4 countries (United States, United Kingdom, Italy and Ghana). We investigated the age of first pain crisis in 555 sickle cell subjects, 344 adults and 211 children. Median age of the first crisis in the whole group was 4 years old, 5 years old among adults and 2 years old among children. Patients from the United States generally reported the first crisis earlier than Ghanaians. Experiencing the first pain crisis early in life correlated with the genotype and disease severity. Early recognition of the first pain crisis could be useful to guide counseling and management of the disease.
AB - Pain is a hallmark of Sickle Cell Disease (SCD) affecting patients throughout their life; the first pain crisis may occur at any age and is often the first presentation of the disease. Universal newborn screening identifies children with SCD at birth, significantly improving morbidity and mortality. Without early screening, diagnosis is generally made after disease manifestations appear. The Consortium for the Advancement of Sickle Cell Research (CASiRe) is an international collaborative group evaluating the clinical severity of subjects with SCD using a validated questionnaire and medical chart review, standardized across 4 countries (United States, United Kingdom, Italy and Ghana). We investigated the age of first pain crisis in 555 sickle cell subjects, 344 adults and 211 children. Median age of the first crisis in the whole group was 4 years old, 5 years old among adults and 2 years old among children. Patients from the United States generally reported the first crisis earlier than Ghanaians. Experiencing the first pain crisis early in life correlated with the genotype and disease severity. Early recognition of the first pain crisis could be useful to guide counseling and management of the disease.
KW - Complications
KW - Newborn screening
KW - Pain crisis
KW - Sickle cell disease
UR - http://www.scopus.com/inward/record.url?scp=85098543977&partnerID=8YFLogxK
U2 - 10.1016/j.bcmd.2020.102531
DO - 10.1016/j.bcmd.2020.102531
M3 - Article
C2 - 33401140
AN - SCOPUS:85098543977
SN - 1079-9796
VL - 88
JO - Blood Cells, Molecules, and Diseases
JF - Blood Cells, Molecules, and Diseases
M1 - 102531
ER -